MainboardGMP
LIVE
LIVE GMP
MakeMyTrip (India) Ltd₹0·Sagar Defence Engineering Ltd₹0·Encube Ethicals Ltd₹0·Arjun Jewellers Ltd₹0·Atomberg Technologies Ltd₹0·GNI Infrastructure Ltd₹0·Punjab Carbonic Ltd₹0·Ratnadeep Retail Ltd.₹0·IFL Finance Ltd.₹0·J Pan Tubular Components Ltd₹0·MakeMyTrip (India) Ltd₹0·Sagar Defence Engineering Ltd₹0·Encube Ethicals Ltd₹0·Arjun Jewellers Ltd₹0·Atomberg Technologies Ltd₹0·GNI Infrastructure Ltd₹0·Punjab Carbonic Ltd₹0·Ratnadeep Retail Ltd.₹0·IFL Finance Ltd.₹0·J Pan Tubular Components Ltd₹0·
Home › IPOs › Manipal Health Enterprises Ltd › Issue Details
MA
Manipal Health Enterprises Ltd
CLOSED NSE & BSE Bookbuilding IPO Fresh capital cum OFS Manipal Health Enterprises IPO GMP
GREY MARKET PREMIUM
₹ + 1
+0% expected return
EST. LISTING PRICE
₹591
Issue Price: ₹ 590
Issue Price
₹590
Face Value
₹2
Lot Size
25 shares
Open Date
29 Jul 2026
Close Date
31 Jul 2026
Allotment
03 Aug 2026
Listing Date
05 Aug 2026
Exchange
NSE & BSE

Manipal Health Enterprises IPO Details: Price, Dates & Financials

The Manipal Health Enterprises IPO pre-issue shareholding stands at 1,179,757,321 shares. The Manipal Health Enterprises IPO post-issue shareholding is 1,315,350,541 shares. This means the Manipal Health Enterprises IPO fresh issue adds 135,593,220 new shares. The Manipal Health Enterprises IPO issue price is ₹590 per share.

Issue Details
Total Shares Offered
280,898
Pre-Issue Shareholding
1,179,757,321 shares
Post-Issue Shareholding
1,315,350,541 shares
Manipal Health Enterprises IPO Issue Details FAQs
Manipal Health Enterprises IPO offers 280,898 shares in total.
Pre-issue shareholding: 1,179,757,321 shares. Post-issue shareholding: 1,315,350,541 shares.
Manipal Health Enterprises IPO is a Fresh capital cum OFS issue. Issue type: Bookbuilding IPO. Face value is ₹2.
The Red Herring Prospectus (RHP) of Manipal Health Enterprises IPO is available on the website of the lead manager and the stock exchange (NSE & BSE) — see the lead manager links on the main page.
The DRHP is the initial offer document filed for regulatory review, while the RHP includes updated disclosures, final issue details, and the price band (when announced). Comparing both documents helps investors identify changes in the Manipal Health Enterprises IPO's financial information, risks, and offer terms before investing in the Manipal Health Enterprises IPO. Reviewing both documents provides a clearer understanding of the Manipal Health Enterprises IPO before making an investment decision.
The DRHP and RHP of the Manipal Health Enterprises IPO disclose potential risks related to the company's business, financial performance, legal matters, and industry conditions. Reviewing these documents helps investors identify potential concerns about the Manipal Health Enterprises IPO, evaluate the Manipal Health Enterprises IPO's risk factors, and make a more informed decision before investing in the Manipal Health Enterprises IPO.

GMP and IPO data are unofficial and for information only — not investment advice. Read the full disclaimer.